Arora Health Powers Launch of Cope Now, a Physician-Guided Prescription Cannabis Telehealth Platform

Arora Health & Aesthetics is powering the launch of Cope Now, an emerging cannabinoid-focused telehealth platform designed to provide patients with access to clinician-led evaluations and a more structured, compliant pathway for physician-guided cannabinoid care. The platform will officially launch in Colorado on May 28, 2026, with plans for nationwide expansion in the coming months.

Cope Now was created to support patients exploring physician-guided cannabinoid care options related to areas commonly associated with wellness conversations, such as sleep and stress, through structured telehealth infrastructure and compliant clinical workflows.

As the clinical provider group supporting the platform, Arora Health will oversee physician-guided evaluations, patient education, intake and follow-up protocols, and broader clinical infrastructure designed to support safe, compliant patient care.

The launch reflects a broader shift occurring across healthcare as patients increasingly seek more personalized, preventive, and integrative approaches to wellness and telehealth care. It also comes as the cannabis industry faces growing demand for stronger clinical oversight, accountability, and evidence-based care models.

“We are entering a new era of medicine where patients are seeking more personalized care experiences, especially in areas like anxiety, sleep, chronic stress, and overall wellness,” said Sean Arora, MD, co-founder and CEO of Arora Health. “For too long, many patients have faced fragmented care experiences and limited long-term wellness support. This partnership represents an opportunity to responsibly expand access to alternative care pathways within a physician-led, highly compliant framework.”

Unlike direct-to-consumer cannabinoid products currently available on the market, the Cope Now platform is designed around structured clinical evaluations, physician oversight, patient education, and integrated follow-up care. The platform aims to provide a medically guided and operationally compliant experience for patients exploring cannabinoid-based care options.

“At Arora, we believe healthcare innovation only matters when it is paired with real medical oversight, patient education, and accountability,” Dr. Arora said. “As cannabinoid-based therapies continue moving into the mainstream healthcare conversation, our goal is not simply access. It is building a physician-led and compliance-focused infrastructure intended to support clinically responsible, operationally compliant patient care.”

The platform launches in collaboration with Kazmira Therapeutics and Cope Now leadership, who have spent years developing pharmaceutical-grade cannabidiol infrastructure, cGMP manufacturing standards, and compounding capabilities designed to support more standardized cannabinoid formulations and regulated clinical pathways.

“Telehealth care continues to fill a major access gap for patients across the United States, especially for those in rural communities or patients seeking more flexible care options,” said Dr. Priyanka Sharma, co-founder and co-CEO of Cope Now. “We will be helping expand access to physician-guided, compounded cannabinoid formulations through a clinically structured telehealth platform. Bringing CBD into a pharmacy and physician-guided framework allows licensed pharmacists and healthcare providers to work together in a way that is familiar, regulated, and focused on patient care.”

The partnership represents a broader evolution across digital health, telemedicine, and integrative medicine, where healthcare companies are being challenged to balance accessibility with stronger clinical infrastructure and compliance standards.

“This is bigger than cannabis. This is about the future of patient-centered medicine,” Dr. Arora said. “Patients want solutions that look beyond symptom suppression and move toward individualized, whole-patient care models. We are proud to help build an ecosystem that combines telehealth, physician oversight, compliance, education, and accessibility in a way that has rarely been done before at scale.”

The Cope Now platform will initially launch for patients in Colorado before expanding into additional states in the near future.